You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PO007LBA/#1550  Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study

Article metrics

Article menu

Download PDFPDF

Plenary 02: Changing the Landscape of Endometrial Cancer
AS04. Endometrial/Uterine corpus cancers
PO007LBA/#1550  Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 2023254040
Dec 2023103016
Jan 202481012
Feb 202469011
Mar 202484014
Apr 202471016
May 202474012
Jun 20243405
Jul 202464011
Aug 20242308
Sep 202454012
Oct 2024801
Total9190158